Sign in
4

Changes in Ownership

Cytosorbents Corp Filed Acc 0001144204-16-107724

Options or other derivatives

  • Chief Medical Officer acquired 22,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
BARTLETT ROBERT HAWES Chief Medical Officer 2016-06-07 Grant or award · Stock Option (right to buy) +2,000 2,000 D
BARTLETT ROBERT HAWES Chief Medical Officer 2016-06-07 Grant or award · Stock Option (right to buy) +20,000 20,000 D
Loading xslF345X03/v441544_4.xml…